Primecap Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308M | Sell |
4,878,037
-909,285
| -16% | -$57.5M | 0.24% | 79 |
|
|
2025
Q1 | $307M | Sell |
5,787,322
-783,868
| -12% | -$41.5M | 0.25% | 80 |
|
|
2024
Q4 | $368M | Sell |
6,571,190
-645,721
| -9% | -$36.1M | 0.28% | 73 |
|
|
2024
Q3 | $378M | Sell |
7,216,911
-95,480
| -1% | -$5M | 0.28% | 75 |
|
|
2024
Q2 | $300M | Sell |
7,312,391
-435,200
| -6% | -$17.9M | 0.22% | 82 |
|
|
2024
Q1 | $336M | Sell |
7,747,591
-305,057
| -4% | -$13.2M | 0.25% | 75 |
|
|
2023
Q4 | $370M | Sell |
8,052,648
-214,773
| -3% | -$9.87M | 0.29% | 72 |
|
|
2023
Q3 | $190M | Sell |
8,267,421
-31,896
| -0.4% | -$731K | 0.16% | 98 |
|
|
2023
Q2 | $137M | Buy |
8,299,317
+692,006
| +9% | +$11.4M | 0.11% | 116 |
|
|
2023
Q1 | $136M | Buy |
7,607,311
+696,169
| +10% | +$12.4M | 0.12% | 119 |
|
|
2022
Q4 | $201M | Sell |
6,911,142
-115,750
| -2% | -$3.37M | 0.18% | 97 |
|
|
2022
Q3 | $172M | Buy |
7,026,892
+662,798
| +10% | +$16.2M | 0.17% | 103 |
|
|
2022
Q2 | $26.4M | Buy |
6,364,094
+72,103
| +1% | +$299K | 0.02% | 201 |
|
|
2022
Q1 | $72.5M | Buy |
6,291,991
+35,000
| +0.6% | +$403K | 0.05% | 167 |
|
|
2021
Q4 | $62.4M | Buy |
6,256,991
+75,900
| +1% | +$757K | 0.04% | 183 |
|
|
2021
Q3 | $80.7M | Buy |
6,181,091
+27,400
| +0.4% | +$358K | 0.06% | 168 |
|
|
2021
Q2 | $120M | Buy |
6,153,691
+148,098
| +2% | +$2.9M | 0.08% | 147 |
|
|
2021
Q1 | $128M | Buy |
6,005,593
+1,663,102
| +38% | +$35.4M | 0.09% | 138 |
|
|
2020
Q4 | $129M | Buy |
4,342,491
+767,800
| +21% | +$22.8M | 0.1% | 138 |
|
|
2020
Q3 | $77.5M | Buy |
3,574,691
+29,900
| +0.8% | +$648K | 0.06% | 150 |
|
|
2020
Q2 | $79M | Buy |
3,544,791
+2,200
| +0.1% | +$49.1K | 0.07% | 152 |
|
|
2020
Q1 | $53.9M | Buy |
3,542,591
+1,448,900
| +69% | +$22.1M | 0.05% | 153 |
|
|
2019
Q4 | $48.1M | Buy |
2,093,691
+1,846,714
| +748% | +$42.4M | 0.03% | 174 |
|
|
2019
Q3 | $5.33M | Buy |
+246,977
| New | +$5.33M | ﹤0.01% | 247 |
|